Dayton, NJ, May 3, 2016 (Newswire.com) - AurobindoPharma USA, a wholly-owned subsidiary of AurobindoPharma Limited of Hyderabad, India, is pleased to announce a planned expansion in Durham, North Carolina.
The Durham facility will become the Aurobindo US center for product development and specialty manufacturing. The North Carolina location is in addition to Aurobindo’s existing US headquarters and operations, which shall remain in New Jersey. For more information, visit www.aurobindousa.com
About AurobindoPharma USA
AurobindoPharma USA is committed to delivering a broad portfolio of quality, affordable generic pharmaceuticals to pharmacists and patients, nationwide.